Financial Performance - The company's operating revenue for Q1 2023 was ¥49,565,770.12, a decrease of 1.11% compared to ¥50,120,791.47 in the same period last year[5] - The net profit attributable to shareholders was a loss of ¥5,874,993.59, representing a decline of 174.06% from a profit of ¥7,925,430.00 in Q1 2022[5] - Basic and diluted earnings per share were both ¥-0.07, a decrease of 153.85% from ¥0.13 in the same period last year[5] - The net profit for Q1 2023 was a loss of CNY 5,236,739.07, compared to a profit of CNY 8,010,471.79 in the same period last year[25] - The total comprehensive income for Q1 2023 was a loss of CNY 5,321,395.94, compared to a gain of CNY 7,996,358.93 in the same period last year[25] Cash Flow - The cash flow from operating activities showed a net outflow of ¥33,706,702.24, which is a 98.03% increase in outflow compared to ¥-23,724,222.22 in the previous year[5] - The cash flow from operating activities showed a net outflow of CNY 33,706,702.24, worsening from a net outflow of CNY 17,020,768.52 in the previous period[27] - The company reported a significant cash inflow from investment activities of CNY 706,506,568.97, compared to CNY 5,500.00 in the previous period[27] - The net cash flow from financing activities was -1,112,441.88 CNY, compared to 5,364,569.84 CNY in the previous period[28] - The cash and cash equivalents at the end of the period amounted to 449,812,592.12 CNY, down from 615,430,174.62 CNY at the beginning of the period[28] - The company experienced a decrease in cash and cash equivalents of 165,617,582.50 CNY during the quarter[28] - The impact of exchange rate changes on cash and cash equivalents was -67,426.53 CNY[28] Assets and Liabilities - Total assets at the end of Q1 2023 were ¥1,442,894,593.48, reflecting a 2.19% increase from ¥1,411,935,814.83 at the end of the previous year[5] - The company's current assets decreased to CNY 1,079,639,191.42 from CNY 1,158,301,958.04, reflecting a decline of approximately 6.8%[21] - The total liabilities increased to CNY 200,794,934.97 from CNY 164,514,760.38, representing a rise of about 22%[22] - The non-current assets rose significantly to CNY 363,255,402.06 from CNY 253,633,856.79, indicating an increase of approximately 43.2%[22] - The company's accounts receivable increased to CNY 310,378,144.74 from CNY 285,268,794.21, showing a growth of approximately 8.8%[21] - The company's short-term borrowings remained stable at CNY 20,022,916.67[22] - The long-term lease liabilities surged to CNY 78,619,858.54 from CNY 13,969,795.36, marking a significant increase of approximately 463%[22] Expenses - Management expenses increased by 130.35% to CNY 14,308,005.47 due to costs related to the construction of the Beijing laboratory and the renovation of the new factory in Xi'an[12] - R&D expenses rose by 106.50% to CNY 3,741,411.95, primarily due to increased labor and material costs associated with project advancement[12] - Total operating costs increased significantly to CNY 54,084,803.99, up 39.4% from CNY 38,758,933.83 in the previous period[23] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 8,327, with no preferred shareholders[14] - The largest shareholder, Li Zexin, holds 41.23% of the shares, totaling 34,800,000 shares[14] Accounting and Policy Changes - The company has implemented changes in accounting policies effective from January 1, 2023, in response to new regulations issued by the Ministry of Finance[6] Investment and Financial Products - The company's financial assets increased by 45.10% to ¥239,881,113.21 due to investments in financial products during the reporting period[11] - Cash invested in financial products reached CNY 776,881,064.99, a staggering increase of 5079.21% compared to CNY 15,000,000.00 in the same period last year[12] - The company reported a significant increase in fair value gains of 2627.87% to CNY 1,189,352.19 from financial products held[12] - Investment income surged by 633.32% to CNY 1,809,157.87, mainly from the redemption of financial products[12]

Dividend Distribution - The company plans to distribute a cash dividend of 1.5 RMB per 10 shares to all shareholders, based on a total share capital of 84,400,000 shares as of December 31, 2022[3] - The company plans to distribute a cash dividend of 1.50 CNY per 10 shares, totaling 12,660,000 CNY (including tax) for the year 2022[166] - The cash dividend represents 100% of the total profit distribution amount, with no shares being issued as bonuses or capital reserves being converted into shares[166] - The total number of shares for the dividend distribution is based on 84,400,000 shares[166] Financial Performance - The company's operating revenue for 2022 was ¥304,150,585.39, representing a 23.87% increase compared to ¥245,531,990.58 in 2021[24] - The net profit attributable to shareholders for 2022 was ¥64,667,157.83, a decrease of 3.55% from ¥67,015,454.07 in 2021[24] - The net profit after deducting non-recurring gains and losses was ¥46,623,463.27, down 23.52% from ¥60,926,625.25 in 2021[24] - The total assets at the end of 2022 reached ¥1,411,935,814.83, a significant increase of 162.12% from ¥535,825,803.96 at the end of 2021[24] - The net assets attributable to shareholders increased by 243.50% to ¥1,230,665,013.85 from ¥358,237,418.99 in 2021[24] - The basic earnings per share for 2022 was ¥0.90, a decrease of 15.09% from ¥1.06 in 2021[24] - The net cash flow from operating activities for 2022 was ¥18,116,370.03, down 13.92% from ¥21,045,751.26 in 2021[24] - The company's total revenue for 2022 was CNY 30,415.06 million, representing a year-on-year increase of 23.87%[56] - The net profit attributable to the parent company was CNY 6,466.72 million, a decrease of 3.55% compared to the previous year[56] - The net cash flow from operating activities was CNY 1,811.64 million, down 13.92% year-on-year[56] Risk Management and Corporate Governance - The company emphasizes the importance of risk awareness regarding forward-looking statements and future plans, indicating that these do not constitute substantial commitments to investors[3] - The company has a comprehensive risk management strategy in place to address potential operational risks[3] - The company maintains a strong commitment to corporate governance and social responsibility, as detailed in the report[5] - The report highlights that all board members attended the meeting to review the annual report, ensuring accountability and transparency in the financial reporting process[3] - The company emphasizes transparency in information disclosure, adhering to regulations and ensuring timely and accurate communication with investors[119] - The company has established a complete and independent asset management system, with no reliance on the controlling shareholder for operational facilities[122] - The company has a robust personnel management system, ensuring independence from the controlling shareholder in labor and salary management[123] - The company has established a strict internal quality control management system to safeguard its reputation and public trust, which are critical for its operations[102] Research and Development - The company has invested in R&D to innovate testing technologies, particularly in reliability testing and electromagnetic compatibility testing[49] - The number of R&D personnel increased to 78 in 2022, a rise of 59.18% from 49 in 2021[70] - R&D investment amounted to ¥17,755,941.35 in 2022, representing 5.84% of total revenue, compared to 4.32% in 2021[70] - The company completed research on microwave switch automatic testing systems, enhancing testing efficiency and reducing human error[70] - The company developed a strong electromagnetic pulse protection plan for drones, improving their resilience against electromagnetic interference[70] - The company has made significant advancements in the adaptability of systems to vibration environments, providing a basis for environmental testing conditions[70] Market Position and Strategy - The company operates in the strategic emerging industry of inspection and testing services, with over 54,000 testing institutions in China and a service output exceeding 400 billion CNY as of the end of 2022[35] - The company is positioned to benefit from the growing demand for third-party testing services as the domestic aircraft manufacturing industry expands[38] - The company is expanding its service capabilities in the commercial aircraft sector, having obtained testing qualifications from China Commercial Aircraft Corporation[47] - The company aims to enhance its financial performance through strategic mergers and acquisitions in the coming years[136] - The company plans to expand its market presence in Southeast Asia, targeting a 10% market share by 2025[146] Employee Management and Development - The total number of employees at the end of the reporting period was 668, with 484 in the parent company and 184 in major subsidiaries[160] - The company has implemented a salary policy aimed at attracting, retaining, and motivating talent, enhancing internal equity and external competitiveness[161] - Various employee benefits include subsidies, holiday bonuses, birthday celebrations, team-building activities, and regular health check-ups[162] - Training programs were organized in 2022 to support employee growth and enhance the company's core competitiveness[163] Compliance and Legal Matters - The company has committed to reducing and regulating related party transactions, ensuring they are conducted on a fair and equitable basis[184] - The company will disclose any failure to execute commitments promptly and transparently to protect investor interests[184] - The company has committed to maintaining the independence of the company in terms of assets, personnel, finance, and operations[185] - The company will ensure compliance with social insurance and housing fund policies for its employees[196] Future Outlook - The company provided a positive outlook for 2023, projecting a revenue growth of 15% to 1.725 billion RMB, driven by new product launches and market expansion efforts[146] - The company's future outlook remains positive, with expectations for growth driven by new product launches and market expansion initiatives[136] - The company is focusing on expanding its market presence and enhancing its product offerings through new technology development[136]

证券代码：301306 证券简称：西测测试 公告编号：2023-014 西安西测测试技术股份有限公司 关于举行 2022 年度业绩网上说明会的公告 出席本次业绩说明会的人员有：公司董事长李泽新先生、董事兼总经理谢朝 阳先生、董事兼副总经理、董事会秘书乔宏元先生，董事兼副总经理、财务负责 人黄婧女士，独立董事马秉晨先生，保荐代表人徐鑫军先生。 为充分尊重投资者、提升交流的针对性，现就公司 2022 年度业绩说明会提 前向投资者公开征集问题，广泛听取投资者的意见和建议。投资者可于 2023 年 5 月 8 日（星期一）12:00 前访问 https://ir.p5w.net/zj/或扫描下方二维码，进入问 题征集专题页面。公司将在 2022 年度业绩说明会上，对投资者普遍关注的问题 进行回答。 欢迎广大投资者积极参与！ 特此公告。 西安西测测试技术股份有限公司 董事会 2023 年 4 月 26 日 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 西安西测测试技术股份有限公司（以下简称"公司"）于 2023 年 4 月 26 日披 露了《2022 年年度报告》全文 ...

证券代码：301306 证券简称：西测测试 编号：2022-001 西安西测测试技术股份有限公司 投资者关系活动记录表 | --- | --- | --- | |-----------------------|--------------------------------------------------------------------|---------------------------------| | 投资者关系活动 \n类别 | 特定对象调研 \n□媒体采访 □业绩说明会 \n□新闻发布会 \n□现场参观 | □分析师会议 \n□路演活动 \n□其他 | | | 第一场： | | | | 广发基金 邱璟旻 | | | | 长江证券 贾少波 | | | | | | | | 第二场： | | | | 兴业机械军工 丁志刚 | | | | 第三场： | | | | 华泰保兴基金 赵健 中信建投基金 孙文 | | | | 中信建投证券 李明斯 | | | | 淳厚基金 刘俊 | | | | | | | | 淳厚基金 薛莉丽 | | | | | | | 参与单位名称及 | 淳厚基金 杨煜城 | | | ...

Revenue and Profitability - Revenue for Q3 2022 was CNY 56,190,689.06, a decrease of 5.17% compared to the same period last year[5] - Net profit attributable to shareholders for Q3 2022 was CNY 23,581,323.57, an increase of 96.01% year-on-year[5] - Basic earnings per share for Q3 2022 was CNY 0.30, up 57.89% from the previous year[5] - The total revenue for the first nine months of 2022 reached ¥133,587,568.81, representing a 31.14% increase compared to ¥101,868,345.82 in the same period of 2021[9] - Net profit for the current period was ¥46,859,073.81, representing a 50.3% increase from ¥31,180,641.70 in the same period last year[20] - Operating profit increased to ¥55,147,550.67, a rise of 43.3% compared to ¥38,525,397.05 in the previous period[20] - The company anticipates continued growth in revenue and profitability as it expands its business operations and product offerings[9] Assets and Equity - Total assets as of September 30, 2022, reached CNY 1,378,454,488.30, a 157.26% increase from the end of the previous year[5] - The company’s total equity attributable to shareholders increased by 238.74% to CNY 1,213,511,171.90 compared to the end of the previous year[5] - As of September 30, 2022, the total assets of Xi'an Xice Testing Technology Co., Ltd. amounted to CNY 1,378,454,488.30, a significant increase from CNY 535,825,803.96 at the beginning of the year[16] - The company's current assets reached CNY 1,192,327,776.99, up from CNY 347,267,480.81 at the start of the year, indicating strong liquidity growth[16] - The equity attributable to shareholders of the parent company increased to CNY 1,213,511,171.90 from CNY 358,237,418.99, showcasing substantial growth in shareholder value[18] Cash Flow and Financial Management - The company reported a cash flow deficit from operating activities of CNY -10,911,308.01, a 57.37% increase in outflow compared to the previous year[5] - Cash and cash equivalents rose to CNY 688,914,456.39 from CNY 51,233,989.07, highlighting a significant improvement in cash flow management[16] - Cash flow from operating activities showed a net outflow of ¥10,911,308.01, an improvement from a net outflow of ¥25,597,353.38 in the prior period[21] - Total cash inflow from financing activities was ¥878,437,456.75, a substantial increase from ¥44,060,898.23 in the previous period, highlighting strong capital raising efforts[22] Expenses and Costs - Research and development expenses for the first nine months of 2022 were CNY 11,016,374.49, reflecting a 52.87% increase due to enhanced innovation efforts[8] - Total operating costs amounted to ¥141,692,907.58, up 20.2% from ¥117,804,138.20 in the prior period[19] - The company reported a significant increase in R&D expenses, which rose to ¥11,016,374.49, compared to ¥7,206,259.23 in the previous period, reflecting a focus on innovation[19] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 17,208, with no preferred shareholders[11] - The largest shareholder, Li Zexin, holds 41.23% of the company's shares, totaling 34,800,000 shares[11] - The total number of restricted shares remained unchanged at 64,389,973, indicating no new restrictions or releases during the reporting period[14] Government Support and Other Income - The company received government subsidies amounting to CNY 18,274,054.36 during the reporting period, contributing to its financial performance[6] - Other income increased significantly by 502.19% to ¥23,635,544.98, primarily due to government subsidies received after the company's listing[9] - Cash received from tax refunds surged by 5471.71% to ¥818,606.50, attributed to policy changes regarding the refund of input VAT[9] Liabilities and Financial Stability - The total liabilities decreased to CNY 160,524,031.32 from CNY 176,466,785.27, reflecting improved financial stability[17] - The company reported a decrease in short-term borrowings to CNY 19,957,400.00 from CNY 40,318,380.10, suggesting a reduction in reliance on debt financing[17]

Financial Performance - The company's operating revenue for the first half of 2022 was ¥118,547,123.45, representing a 20.36% increase compared to ¥98,493,202.68 in the same period last year[24]. - The net profit attributable to shareholders for the first half of 2022 was ¥22,680,064.86, up 19.29% from ¥19,012,653.55 in the previous year[24]. - The net profit after deducting non-recurring gains and losses was ¥19,776,537.60, reflecting a 22.58% increase from ¥16,133,663.05 in the same period last year[24]. - The basic earnings per share increased to ¥0.36, a 20.00% rise from ¥0.30 in the previous year[24]. - The company reported a total comprehensive income of ¥23,168,765.04 for the first half of 2022, compared to ¥19,031,040.24 in the same period of 2021, marking an increase of 21.2%[150]. - The net profit for the first half of 2022 was CNY 22,664,948.23, an increase of 5.75% compared to CNY 21,434,318.06 in the same period of 2021[153]. - Operating profit reached CNY 26,678,040.44, up from CNY 25,646,558.17, reflecting a growth of 4.02% year-over-year[153]. - The total revenue from operating activities was CNY 99,667,290.77, compared to CNY 81,859,309.49 in the first half of 2021, indicating a growth of 21.77%[156]. Assets and Liabilities - The total assets at the end of the reporting period were ¥553,836,204.15, which is a 3.36% increase from ¥535,825,803.96 at the end of the previous year[24]. - The total liabilities decreased from CNY 176,466,785.27 to CNY 171,308,420.42, a reduction of about 2.09%[143]. - The company's equity attributable to shareholders increased from CNY 358,237,418.99 to CNY 381,022,872.41, reflecting a growth of approximately 6.35%[143]. - The company's current assets totaled CNY 369,081,461.38 as of June 30, 2022, compared to CNY 347,267,480.81 at the start of the year, indicating an increase of about 6.83%[141]. - The total liabilities decreased from 175,688,000.00 CNY to 175,000,000.00 CNY, reflecting a reduction of approximately 0.4%[160]. Cash Flow - The net cash flow from operating activities was negative at -¥7,578,997.13, a decline of 233.32% compared to a positive cash flow of ¥5,684,887.65 in the same period last year[24]. - The cash flow from operating activities showed a net outflow of CNY -7,578,997.13, a decline from a net inflow of CNY 5,684,887.65 in the previous year[156]. - The cash and cash equivalents decreased from CNY 51,233,989.07 to CNY 31,245,016.61, representing a decline of approximately 38.96%[141]. - The company's cash inflow from financing activities was 36,113,300.52 CNY, an increase of 48.3% from 24,354,073.95 CNY in the previous period[159]. Research and Development - Research and development investment increased by 41.57% to ¥6,198,235.14, reflecting the company's commitment to enhancing testing capabilities and developing automated testing systems[60]. - The company holds 17 patents and 86 software copyrights, emphasizing its commitment to R&D and innovation[46]. - The company has initiated research and development for new technologies aimed at enhancing product offerings and improving operational efficiency[169]. Market Position and Strategy - The company plans to expand its laboratory network to regions including East China, North China, South China, and Central China[47]. - The company has established long-term partnerships with major military and aerospace groups, enhancing its competitive position in the market[49]. - The company plans to continue expanding its market presence and investing in new technologies to drive future growth[149]. - The management provided a positive outlook for the second half of 2022, expecting continued growth in revenue and profitability[169]. Risk Management - The management has outlined potential risk factors and countermeasures in the report, emphasizing the importance of investor awareness[3]. - The company plans to enhance its service capabilities and diversify its customer base to reduce customer concentration risks[78]. Corporate Governance - The company has maintained a stable financial policy, ensuring the safety of assets and funds while protecting shareholder interests[92]. - The financial statements for the first half of 2022 were approved by the board on August 26, 2022[173]. - The company has no significant doubts regarding its ability to continue as a going concern for the next 12 months[175]. Shareholder Information - The total number of shares before the change was 63,300,000, representing 100.00% of the total shares[122]. - The largest shareholder, Li Zexin, holds 54.98% of the shares, totaling 34,800,000 shares[125]. - The company has not issued any new shares or conducted any public offerings during the reporting period[124]. Compliance and Standards - The financial reports comply with the requirements of enterprise accounting standards, reflecting the company's financial status, operating results, and cash flows accurately[176]. - The accounting period for the financial information is from January 1, 2022, to June 30, 2022[177].

Financial Performance - The company's operating revenue for the first half of 2022 was ¥118,547,123.45, representing a 20.36% increase compared to ¥98,493,202.68 in the same period last year[24]. - The net profit attributable to shareholders for the first half of 2022 was ¥22,680,064.86, up 19.29% from ¥19,012,653.55 in the previous year[24]. - The net profit after deducting non-recurring gains and losses was ¥19,776,537.60, reflecting a 22.58% increase from ¥16,133,663.05 in the same period last year[24]. - The basic earnings per share increased to ¥0.36, a 20.00% rise from ¥0.30 in the previous year[24]. - The total operating revenue for the first half of 2022 reached CNY 118,547,123.45, an increase of 20.4% compared to CNY 98,493,202.68 in the same period of 2021[148]. - The net profit for the first half of 2022 was CNY 23,063,376.48, representing a growth of 21.3% compared to CNY 19,029,454.32 in the first half of 2021[149]. - The total comprehensive income for the first half of 2022 was 4,948 million yuan, showing a significant increase compared to the previous period[168]. - The net profit attributable to shareholders for the first half of 2022 was 370.4 million yuan, reflecting a growth of 22.66% compared to the same period last year[168]. Assets and Liabilities - The total assets at the end of the reporting period were ¥553,836,204.15, which is a 3.36% increase from ¥535,825,803.96 at the end of the previous year[24]. - The total liabilities decreased from CNY 176,466,785.27 to CNY 171,308,420.42, a reduction of about 2.3%[143]. - The company's equity attributable to shareholders increased from CNY 358,237,418.99 to CNY 381,022,872.41, representing a growth of approximately 6.35%[143]. - The company's total assets at the end of the reporting period amounted to 63,300 million yuan, with a total liability of 172,600 million yuan[169]. - The total equity at the end of the current period is CNY 310,919,170, reflecting an increase from the previous balance[165]. Cash Flow - The net cash flow from operating activities was negative at -¥7,578,997.13, a decline of 233.32% compared to a positive cash flow of ¥5,684,887.65 in the same period last year[24]. - The cash flow from operating activities showed a net outflow of CNY -7,578,997.13, a decline from a net inflow of CNY 5,684,887.65 in the previous year[156]. - The cash and cash equivalents decreased from CNY 51,233,989.07 to CNY 31,245,016.61, reflecting a decline of approximately 38.96%[141]. - The net increase in cash and cash equivalents was -12,995,615.19 CNY, compared to -8,292,694.24 CNY in the previous period, indicating a worsening cash position[159]. Research and Development - Research and development investment increased by 41.57% to ¥6,198,235.14, reflecting the company's commitment to enhancing testing capabilities and developing automated testing systems[60]. - The company has allocated 5,000,000.00 CNY for research and development of new products in the upcoming period, which is a 25% increase from the previous year[162]. - The company has initiated research and development for new technologies aimed at enhancing product offerings and improving operational efficiency[169]. Market Position and Strategy - The company plans to expand its laboratory network to regions including East China, North China, South China, and Central China[47]. - The company plans to continue expanding its market presence and investing in new technologies to drive future growth[149]. - The company is focusing on strategic acquisitions to enhance its market position and drive future growth[165]. - The management provided a positive outlook for the second half of 2022, expecting continued growth in revenue and profitability[169]. Customer and Revenue Concentration - The top five customers contributed 63.95% of the company's revenue in the first half of 2022, down from 66.45% in the same period of 2021[78]. - The company plans to enhance its service capabilities and diversify its customer base to reduce customer concentration risks[78]. Corporate Governance and Compliance - The company has not engaged in any entrusted financial management or derivative investments during the reporting period[72][73]. - The company has not sold any significant assets or equity during the reporting period[75][76]. - The company reported no significant environmental issues or administrative penalties during the reporting period[91]. - The company maintained a robust financial policy, ensuring asset and fund safety, with no instances of fund occupation by controlling shareholders or related parties[92]. - The financial statements for the first half of 2022 were approved by the board on August 26, 2022[173]. Shareholder Information - The largest shareholder, Li Zexin, holds 54.98% of the shares, amounting to 34,800,000 shares[125]. - The company has a total of 8 shareholders, with no special voting rights shares reported[125]. - The company has not conducted any repurchase transactions during the reporting period[128]. Operational Highlights - The company is a major third-party inspection and testing service provider for military and civil aircraft products, offering services such as environmental and reliability testing, electronic component testing, and electromagnetic compatibility testing[34]. - The company has a complete range of testing capabilities, including 35 types of tests for environmental and reliability assessments, which help improve product reliability and reduce development cycles[35]. - The company conducts electromagnetic compatibility tests to ensure the normal operation of electronic devices in complex electromagnetic environments[39]. Financial Reporting and Standards - The financial reports comply with the requirements of enterprise accounting standards, reflecting the company's financial status, operating results, and cash flows accurately[176]. - The accounting period for the financial information is from January 1, 2022, to June 30, 2022[177].